Kinetically Competing Huntingtin Aggregation Pathways Control Amyloid Polymorphism and Properties
- 20 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 51 (13) , 2706-2716
Abstract
In polyglutamine (polyQ) containing fragments of the Huntington’s disease protein huntingtin (htt), the N-terminal 17 amino acid httNT segment serves as the core of α-helical oligomers whose reversible assembly locally concentrates the polyQ segments, thereby facilitating polyQ amyloid nucleation. A variety of aggregation inhibitors have been described that achieve their effects by neutralizing this concentrating function of the httNT segment. In this paper we characterize the nature and limits of this inhibition for three means of suppressing httNT-mediated aggregation. We show that the previously described action of httNT peptide-based inhibitors is solely due to their ability to suppress the httNT-mediated aggregation pathway. That is, under httNT inhibition, nucleation of polyQ amyloid formation by a previously described alternative nucleation mechanism proceeds unabated and transiently dominates the aggregation process. Removal of the bulk of the httNT segment by proteolysis or mutagenesis also blocks the httNT-mediated pathway, allowing the alternative nucleation pathway to dominate. In contrast, the previously described immunoglobulin-based inhibitor, the antihttNT VL 12.3 protein, effectively blocks both amyloid pathways, leading to stable accumulation of nonamyloid oligomers. These data show that the httNT-dependent and -independent pathways of amyloid nucleation in polyQ-containing htt fragments are in direct kinetic competition. The results illustrate how amyloid polymorphism depends on assembly mechanism and kinetics and have implications for how the intracellular environment can influence aggregation pathways.Keywords
This publication has 68 references indexed in Scilit:
- Inhibiting the Nucleation of Amyloid Structure in a Huntingtin Fragment by Targeting α-Helix-Rich Oligomeric IntermediatesJournal of Molecular Biology, 2012
- Slow Amyloid Nucleation via α-Helix-Rich Oligomeric Intermediates in Short Polyglutamine-Containing Huntingtin FragmentsJournal of Molecular Biology, 2012
- An Antisense CAG Repeat Transcript at JPH3 Locus Mediates Expanded Polyglutamine Protein Toxicity in Huntington's Disease-like 2 MiceNeuron, 2011
- The Aggregation-Enhancing Huntingtin N-Terminus Is Helical in Amyloid FibrilsJournal of the American Chemical Society, 2011
- Assays for studying nucleated aggregation of polyglutamine proteinsMethods, 2011
- Essential Role of Coiled Coils for Aggregation and Activity of Q/N-Rich Prions and PolyQ ProteinsCell, 2010
- Aβ(1–40) Forms Five Distinct Amyloid Structures whose β-Sheet Contents and Fibril Stabilities Are CorrelatedJournal of Molecular Biology, 2010
- Modulation of Polyglutamine Conformations and Dimer Formation by the N-Terminus of HuntingtinJournal of Molecular Biology, 2010
- Serines 13 and 16 Are Critical Determinants of Full-Length Human Mutant Huntingtin Induced Disease Pathogenesis in HD MiceNeuron, 2009
- Plasticity of Amyloid FibrilsBiochemistry, 2006